A patient and caregiver perspective and plain language summary of the ARASENS trial
Kind regards,
Jade ParkerSenior Editor, Oncology Central
Topics: Cancer biology and pathology | Clinical trials | Drug approvals | Drug development | Diagnostics | Epidemiology | Genetics and genomics | Immuno- oncology | Industry and business | Patient perspective | Personalized medicine | Preclinical research and trials | Prevention and screening | Targeted therapies |
Future Science Ltd, Unitec House, 2 Albert Place, Finchley Central, London N3 1QB, UK, +44 (0) 20 8371 6090
Unsubscribe Manage preferences
Privacy Policy | Terms & Conditions
